Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Inhibition of rat somatostatin receptor type 5
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Inhibition of human somatostatin receptor type 3
Assay data:2 Activity ≤ 1 µM, 3 Tested
SummaryCompounds, activity ≤ 1 µMPubMed CitationRelated BioAssays by Target
Binding affinity to human somatostatin receptor type 3
Agonist activity at human SST3 receptor expressed in CHO-K1 cells assessed as inhibition of NKH477-induced intracellular cAMP accumulation incubated for 20 mins by HTRF assay
Assay data:1 Active, 7 Activity ≤ 1 µM, 7 Tested
Binding Assay from US Patent US11834435: "SSTR4 agonist salts"
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by Target
Displacement of [125I]-Tyr-SRIF 14 from SST3 receptor (unknown origin) expressed in membrane measured after 90 mins by gamma counting analysis
Assay data:10 Active, 33 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Agonist activity at human SST3
Assay data:2 Active, 2 Activity ≤ 1 µM, 2 Tested
Activity Assays from US Patent US11136312: "3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof"
Assay data:66 Active, 7 Activity ≤ 1 nM, 62 Activity ≤ 1 µM, 66 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMRelated BioAssays by DepositorRelated BioAssays by Target
Radioligand Binding Assay from US Patent US11136312: "3,4,5-trisubstituted-1,2,4-triazoles and 3,4,5-trisubstituted-3-thio-1,2,4-triazoles and uses thereof"
Assay data:71 Active, 6 Activity ≤ 1 nM, 70 Activity ≤ 1 µM, 71 Tested
Radioligand Binding Assays from US Patent US10675268: "Somatostatin receptor subtype 4 (SSTR4) agonists"
Assay data:20 Active, 20 Activity ≤ 1 µM, 20 Tested
Radioligand Binding Assays from US Patent US10577336: "Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists"
Assay data:4 Active, 4 Activity ≤ 1 µM, 4 Tested
Radioligand Binding Assay from US Patent US8952128: "Somatostatin-dopamine chimeric analogs"
Assay data:49 Active, 42 Activity ≤ 1 nM, 49 Activity ≤ 1 µM, 49 Tested
Binding Scintillation Proximity Assay from US Patent US8754099: "Oxadiazole beta carboline derivatives as antidiabetic compounds"
Assay data:5 Active, 5 Activity ≤ 1 µM, 5 Tested
Radioligand Binding Assay from US Patent US9789082: "Somatostatin receptor subtype 4 (SSTR4) agonists"
Radioligand Binding Assays from US Patent US10183940: "Aryl and heteroaryl-fused tetrahydro-1,4-oxazepine amides as somatostatin receptor subtype 4 (SSTR4) agonists"
Assay data:9 Active, 9 Activity ≤ 1 µM, 9 Tested
Radiogland Binding Assays from US Patent US10166214: "Somatostatin receptor subtype 4 (SSTR4) agonists"
Radioligand Binding Assays from US Patent US10071974: "Morpholine and 1,4-oxazepane amides as somatostatin receptor subtype 4 (SSTR4) agonists"
Somatostatin sst3 Eurofins-Panlabs radioligand binding assay
Assay data:2 Tested
SummaryRelated BioAssays by Target
PRESTO-Tango GPCRome screening (SSTR3)
Assay data:1 Tested
Somatostatin CEREP ligand profiling
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on